MedDataX Logo

Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* Sequences

NCT ID: NCT01121094

Last Updated: 2010-05-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-06-30

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to prospectively evaluated the T2\* values of normal feti.A standardized scale of T2\* values for fetal and neonatal iron organ overload have yet to be reported or devised.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hepcidin Levels in Preterm Infants

NCT01539356

Preterm Infants Anemia of Prematurity Neonatal Sepsis
COMPLETED

The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia

NCT04598750

Neonatal Thrombocytopenia Bleeding
RECRUITING

PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants

NCT03645655

Hepatoblastoma Hepatic Hemangioendothelioma
COMPLETED

Safety and Efficacy of Oral Bovine Lactoferrin

NCT04094597

Neonatal SEPSIS
COMPLETED EARLY_PHASE1

the Prognosis of Fetoscopy Treatment of Twin Transfusion Syndrome

NCT04952415

Twin Diseases
NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to prospectively evaluate the T2\* values of normal feti. This study will be offered to mothers undergoing fetal MRI for any indication. Subjects will be required to sign an informed consent from. The addition of T2\* sequences will add 2-4 minutes to the whole scan, not exposing the mother or the fetus to ionizing radiation or the administration of contrast material. A standardized scale has been created and multi-center studies have been conducted using different vendor scanners in order to verify the consistency of these scale. T2 and T2\* sequences have been addressed anecdotally in the literature as non invasive options for the evaluation fetal iron deposition . However, a standardized scale of T2\* values for fetal and neonatal iron organ overload have yet to be reported or devised.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iron Overload

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any MRI study for fetus

Exclusion Criteria

* Known iron deposition problem in the mother of fetus
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sheba Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sheba Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sheba medical center

Tel Litwinsky, Israel, Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Orly Goitein, MD

Role: CONTACT

[email protected]
+972 3 5302530

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Orly Goitein, MD

Role: primary

+972 3 5302530

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SHEBA-09-7502-OG-SMC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Is Primiparity a Risk Factor for Neonatal Hyperbilirubinemia?
NCT03329040 COMPLETED
Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia
NCT06984445 RECRUITING
Serum Erythropoietin Level in Perinatal Asphyxia
NCT05018364 COMPLETED
Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency
NCT02594904 UNKNOWN PHASE4
Iron Metabolism in Small Pre Term Newborns
NCT01443195 UNKNOWN NA
Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns
NCT00004382 COMPLETED PHASE2
Trial of Maternal Oxygen for Fetal Left Heart Hypoplasia
NCT02965638 ACTIVE_NOT_RECRUITING NA
Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respect to HAS 2014 Recommendations
NCT06909487 RECRUITING
Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH
NCT06832800 RECRUITING EARLY_PHASE1
Effect of Intravenous Fluid Supplementation on Serum Bilirubin and Cardiorespiratory Parameters in Preterm Infants During Phototherapy
NCT01550627 COMPLETED EARLY_PHASE1
Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
NCT02446951 COMPLETED
Iron and Retinopathy of Prematurity (ROP)
NCT05133999 COMPLETED
Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity
NCT00339001 UNKNOWN
Thyroid Function in Sick and Healthy Preterm Infants Admitted in NICU of Assiut University Children Hospital
NCT05632965 UNKNOWN
Measurement of Cerebral and Peripheric Tissue Oxygenation in Anemic Preterm Infants Who Underwent Blood Transfusion
NCT01251068 UNKNOWN NA
Does Placenta Pathology Predict Outcome of Neonates With Hypoxic Ischemic Encephalopathy?"
NCT03284528 COMPLETED
The Correlation Between Red Cell Transfusion and Complications of Prematurity
NCT07123948 NOT_YET_RECRUITING
Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)
NCT00945789 COMPLETED PHASE1/PHASE2
Erythropoietin in HIE Neonate
NCT06590155 NOT_YET_RECRUITING EARLY_PHASE1
Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease
NCT00288600 COMPLETED PHASE4
The Benefit in Terms of Improvement in Haemoglobin Level at 6 Months in Premature Babies Receiving Alternate Iron Substitution 4 Times a Week Compared to a Daily Substitution
NCT06624709 RECRUITING NA
Fetoscopic Selective Laser Photocoagulation in Twin-Twin Transfusion Syndrome
NCT00345852 UNKNOWN NA
Transcutaneous Bilirubinometry in Neonates With the BiliCare System Compared to the Invasive TSB Test
NCT02372071 COMPLETED NA
The Reduced Thyroid Function of the Premature Newborn: Relation With Molecular Changes in the Placenta and Maternal Thyroid Hormone Status and Neurodevelopmental Implications
NCT01466023 COMPLETED
Analyses of Anemia in Very Low Birth Weight (VLBW) Infants.
NCT05949788 COMPLETED